Viewing Study NCT01627106


Ignite Creation Date: 2025-12-26 @ 4:01 PM
Ignite Modification Date: 2026-05-07 @ 5:24 AM
Study NCT ID: NCT01627106
Status: WITHDRAWN
Last Update Posted: 2013-08-26
First Post: 2012-06-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study Comparing Vernakalant Therapy to Amiodarone Therapy in Acute Management of Recent Onset Atrial Fibrillation (AF) (MK-6621-055)
Sponsor: Advanz Pharma
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 6621-055
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators